References-
[1] Yang W, Cao Q, Qin L, Wang X, Cheng Z, Pan A, et al. Clinical
characteristics and imaging manifestations of the 2019 novel coronavirus
disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang,
China. J Infect. 2020;80:388–93.
[2] Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a
viral land: A tale of two pathogens. Indian J Ophthalmol.
2021;69:244-52.
[3] Honavar SG. Code Mucor: Guidelines for the Diagnosis, Staging
and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of
COVID-19. Indian J Ophthalmol. 2021;69:1361-5.
[4] Mathur S, Karimi A, Mafee MF. Acute optic nerve infarction
demonstrated by diffusion-weighted imaging in a in a case of
rhinocerebral mucormycosis. Am J Neuroradiol. 2007;28:489–90.
[5] Chae HK, Lim J, Lee SC, Kim KS. The Significance of ”Black
Turbinate Sign” on MRI. Ear Nose Throat J. 2020;99:395-6.
[6] Joshi AR, Muthe MM, Patankar SH, Athawale A, Achhapalia Y. CT
and MRI Findings of Invasive Mucormycosis in the Setting of COVID-19:
Experience From A Single Center in India. AJR Am J Roentgenol. 2021 Jun
23. doi:10.2214/AJR.21.26205.
[7] Safder S, Carpenter JS, Roberts TD, Bailey N. The ”Black
Turbinate” sign: An early MR imaging finding of nasal mucormycosis. AJNR
Am J Neuroradiol. 2010;31:771-4.
[8] Mohindra S, Mohindra S, Gupta R, Bakshi J, Gupta SK.
Rhinocerebral mucormycosis: the disease spectrum in 27 patients.
Mycoses. 2007;50:290-6.
[9] Ferguson BJ. Mucormycosis of the nose and Paranasal sinuses.
Otolaryngol Clin North Am. 2000;3:349-65.
[10] Gillespie MB, O’Malley BW. An algorithmic Approach to the
diagnosis and management of invasive fungal rhinosinusitis in the
immunocompromised patient. Otolaryngol Clin North Am 2000; 33:323-34.